Physician profile
Patrick Kroenung
NPI 1427788579
$6,856.31
in general payments reported to CMS, 2019-2025
15 companies · $5,548 in 2025
The $5,548 reported for 2025 was more than what 83% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $147 · 2023: $574 · 2024: $587 · 2025: $5,548.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,103 · Travel and Lodging: $2,606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,102.65 |
| Travel and Lodging | $2,606.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $2,421.80 | 2023-2025 | |
| Globus Medical, INC. | $1,998.60 | 2025 | Alif, Senza, Independence |
| Depuy Synthes Sales INC. | $595.78 | 2023-2025 | Na, Gryphon Orthocord, Va-Lcp |
| Stryker Corporation | $421.76 | 2025 | Triathlon, Pangea, Tornier Perform Reversed Glenoid |
| Axogen | $298.09 | 2022-2023 | Avance Nerve Graft |
| Orthopediatrics Corp. | $153.37 | 2023 | |
| Bioventus LLC | $149.93 | 2025 | Xcell |
| Medical Device Business Services, INC. | $144.31 | 2025 | Attune |
| Davol INC. | $140.73 | 2025 | |
| Paragon 28, INC. | $123.66 | 2025 | Apex 3d |
| Zimvie INC. | $121.34 | 2023 | |
| Biocomposites INC | $110.88 | 2024 | |
| Amgen INC. | $100.80 | 2024 | Evenity |
| Pinnacle, INC | $59.11 | 2023-2025 | |
| Medtronic, INC. | $16.15 | 2023 | Catalyft Pl Expandable Interbody System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Kroenung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.